system
capillari
leak
syndrom
appear
cell
attack
ann
intern
med
brett
j
gerlach
h
nawroth
p
et
al
tumor
necrosi
factorcachectin
increas
permeabl
endotheli
cell
monolay
mechan
involv
regulatori
g
protein
j
exp
med
sampaio
ep
sarno
en
galilli
r
et
al
thalidomid
select
inhibit
tumor
necrosi
factor
alpha
product
stimul
human
monocyt
j
exp
med
editor
meat
substitut
market
brand
name
quorn
quorn
food
inc
riversid
connecticut
made
process
fusarium
venenatum
fungu
product
market
unit
kingdom
year
unit
state
sinc
caus
advers
reaction
certain
person
common
reaction
vomit
diarrhea
report
center
scienc
public
interest
suggest
symptom
involv
recent
studi
link
sever
hypersensit
reaction
patient
asthma
immunoglobulin
e
antibodi
specif
ribosom
protein
quorn
center
scienc
public
interest
web
site
www
quorncomplaintscom
mail
receiv
report
advers
reaction
tabl
includ
unit
kingdom
unit
state
elsewher
europ
report
support
correspond
telephon
call
one
report
anaphylaxi
concern
man
experienc
vomit
diarrhea
follow
sever
breathless
numb
mouth
lip
loss
feel
arm
leg
admit
hospit
advis
carri
epipen
king
pharmaceut
inc
bristol
tennesse
discharg
allergi
anoth
report
concern
woman
allergi
seafood
poultri
kidney
bean
chickpea
admit
follow
anaphylact
reaction
attribut
quorn
within
minut
ingest
quorn
develop
facial
swell
urticaria
wheezi
unabl
speak
blood
pressur
mm
hg
given
adrenalin
hydrocortison
chlorpheniramin
advis
carri
epipen
ascertain
frequenc
reaction
quorn
well
common
food
allergen
commiss
telephon
survey
british
consum
age
year
older
tabl
respond
ask
allerg
variou
food
consum
quorn
n
ask
experienc
certain
symptom
eat
quorn
although
sampl
size
limit
sensit
quorn
appear
least
common
allergi
major
food
allergen
symptom
attribut
quorn
includ
stomachach
cramp
n
diarrhea
n
vomit
n
indigest
nausea
hive
rash
headach
flatul
question
wisdom
introduc
food
suppli
ingredi
appear
caus
sever
gastrointestin
reaction
anaphylaxi
symptom
michael
f
jacobson
phd
center
scienc
public
interest
washington
c
editor
man
known
compens
chronic
hepat
b
admit
march
histori
malais
anorexia
teacolor
urin
examina
meqml
diagnosi
acut
reactiv
chronic
hepat
b
treatment
lamivudin
mg
daili
start
remain
clinic
stabl
biochem
improv
day
develop
fever
focal
sourc
infect
found
chest
radiograph
normal
despit
empir
intraven
cefotaxim
levofloxacin
fever
persist
chest
radiograph
day
show
bilater
air
space
consolid
condit
deterior
next
day
involv
respiratori
failur
shock
admit
intens
care
unit
time
appar
contract
sever
acut
respiratori
syndrom
sar
hospit
outbreak
diseas
subsequ
confirm
sarscoronaviru
sarscov
isol
nasopharyng
aspir
despit
mechan
ventil
therapeut
intervent
includ
broadspectrum
antibiot
ribavirin
puls
methylprednisolon
condit
worsen
led
multipl
system
organ
dysfunct
patient
die
day
postmortem
examin
reveal
extens
consolid
lung
diffus
alveolar
damag
hyalin
membran
featur
commonli
found
patient
die
sar
liver
cirrhot
show
sever
hepatocyt
dropout
small
island
hepatocyt
left
parenchyma
figur
portal
tract
minimaltomild
chronic
inflammatori
cell
infiltr
portal
tract
show
lymphocyt
deplet
figur
b
c
moder
periport
cholangiolar
transform
figur
furthermor
sever
cholestasi
demonstr
larg
bile
plug
observ
within
bile
canaliculi
figur
e
also
mild
macrovesicular
steatosi
without
accompani
hyalin
chang
figur
f
sarscov
could
isol
liver
tissu
peiri
et
al
found
higher
percentag
patient
hbsag
posi
tiviti
among
sar
patient
develop
acut
respiratori
distress
syndrom
howev
whether
wors
pulmonari
outcom
directli
relat
chronic
hepat
b
known
patient
reactiv
chronic
hepat
b
probabl
major
caus
death
patient
improv
develop
symptom
sar
lamivudin
treatment
without
sar
like
would
recov
convers
impair
hepat
function
might
aggrav
cours
sar
contribut
death
interv
onset
fever
death
much
shorter
day
mean
admissiontodeath
time
day
sar
patient
die
postmortem
find
shed
light
effect
sar
patient
hepat
lymphocyt
deplet
portal
tract
unusu
submass
necrosi
liver
due
exacerb
chronic
hepat
b
often
associ
promin
lymphocyt
infiltr
peripher
lymphopenia
import
featur
sar
appear
affect
liver
even
face
hepat
interestingli
lymphocyt
deplet
patient
reminisc
hepat
histolog
patient
full
blown
aid
may
reflect
overwhelm
effect
sar
immun
system
sarscov
could
isol
liver
tissu
direct
cytopath
effect
sarscov
liver
unlik
cytokin
dysregul
probabl
import
pathogenesi
sar
henc
steroid
immunosuppress
agent
use
firstlin
therapi
immunosuppress
may
predispos
flare
chronic
hepat
b
propos
use
prophylact
antivir
therapi
lamivudin
begin
immunosuppress
treatment
sar
patient
chronic
hepat
b
decreas
viral
load
likelihood
reactiv
hepat
b
may
reduc
meanwhil
studi
warrant
investig
whether
chronic
hepat
b
